Thromboxane-induced pulmonary vasoconstriction: involvement of calcium |
| |
Authors: | Farrukh I S; Michael J R; Summer W R; Adkinson N F Jr; Gurtner G H |
| |
Abstract: | Infusion of tert-butyl hydroperoxide (t-bu-OOH) or arachidonic acid into rabbit pulmonary arteries stimulated thromboxane B2 (TxB2) production and caused pulmonary vasoconstriction. Both phenomena were blocked by cyclooxygenase inhibitors or a thromboxane synthase inhibitor. The increase in pulmonary arterial pressure caused by either t-bu-OOH or arachidonic acid infusion correlated with the concentration of TxB2 in the effluent perfusate. The concentration of TxB2 in the effluent perfusate, however, was always 10-fold greater after arachidonic acid infusion. In the rabbit pulmonary vascular bed lipoxygenase products did not appear involved in the vasoactive response to t-bu-OOH or exogenous arachidonic acid infusion. Calcium entry blockers or a calcium-free perfusate prevented the thromboxane-induced pulmonary vasoconstriction. Calmodulin inhibitors also blocked the pulmonary vasoconstriction induced by t-bu-OOH without affecting the production of TxB2 or prostacyclin. These results suggest that thromboxane causes pulmonary vasoconstriction by increasing cytosol calcium concentration. |
| |
Keywords: | |
|
| 点击此处可从《Journal of applied physiology (Bethesda, Md. : 1985)》浏览原始摘要信息 |
| 点击此处可从《Journal of applied physiology (Bethesda, Md. : 1985)》下载免费的PDF全文 |